Skip to main content
Top
Published in: BMC International Health and Human Rights 1/2012

Open Access 01-12-2012 | Research article

Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, Ethiopia

Authors: Amenu Wesen, Getnet Mitike

Published in: BMC International Health and Human Rights | Issue 1/2012

Login to get access

Abstract

Background

The risk of acquiring tuberculosis by People living with HIV (PLHIV) could significantly be reduced through provision of isoniazid preventive therapy (IPT). In Ethiopia, it is neither practiced well nor researched in depth. Our objective was to assess IPT provision and awareness among PLHIV in Addis Ababa City Administration.

Methods

Between February 2008 and May 2008, a cross sectional facility-based survey was conducted by exit interview of 406 PLHIV from six health facilities. The findings were analyzed and described in this report.

Results

The proportion of PLHIV ever had been provided with IPT were 74 of 231 TB free PLHIV (32.0%) and the proportion of having information about IPT among study participants was 29.8%. Females were about two times more informed about the provision of IPT in their health facilities than males [AOR (95%CI): 2.18 (1.31-3.61)].

Conclusions

We conclude that the practice of provision of IPT for PLHIV is high, but there is room for improvement. Provision of INH for TB free PLHIV has to be strengthened with better diagnostic facilities to certainly rule out active TB cases.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: Guidelines for the implementation of collaborative TB and HIV program activities. 2003, Geneva, Switzerland WHO: Guidelines for the implementation of collaborative TB and HIV program activities. 2003, Geneva, Switzerland
2.
go back to reference Wilkinson D: Drugs for preventing tuberculosis in HIV infected persons. Chocrane Database Sys Rev. 2000, 2: CD000171- Wilkinson D: Drugs for preventing tuberculosis in HIV infected persons. Chocrane Database Sys Rev. 2000, 2: CD000171-
3.
go back to reference Pape JW, Jean SS, Hafner A, Johnson WD: Effect of Isoniazid prophylaxis on incidence of active tuberculosis on HIV infection. Lancet. 1993, 342 (8866): 268-272. 10.1016/0140-6736(93)91817-6.CrossRefPubMed Pape JW, Jean SS, Hafner A, Johnson WD: Effect of Isoniazid prophylaxis on incidence of active tuberculosis on HIV infection. Lancet. 1993, 342 (8866): 268-272. 10.1016/0140-6736(93)91817-6.CrossRefPubMed
4.
go back to reference Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD, Pape JW: Effect of post treatment isoniazid on prevention of recurrent tuberculosis in HIV -1 infected individuals: a randomized trial. Lancet. 2000, 356 (9240): 1470-1474. 10.1016/S0140-6736(00)02870-1.CrossRefPubMed Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD, Pape JW: Effect of post treatment isoniazid on prevention of recurrent tuberculosis in HIV -1 infected individuals: a randomized trial. Lancet. 2000, 356 (9240): 1470-1474. 10.1016/S0140-6736(00)02870-1.CrossRefPubMed
5.
go back to reference Churchyard GJ, Fielding K, Charalambous S, Day JH, Corbett EL, Hayes RJ, Chaisson RE, De Cock KM, Samb B, Grant AD: Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy. AIDS. 2003, 17 (14): 2063-2070. 10.1097/00002030-200309260-00007.CrossRefPubMed Churchyard GJ, Fielding K, Charalambous S, Day JH, Corbett EL, Hayes RJ, Chaisson RE, De Cock KM, Samb B, Grant AD: Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy. AIDS. 2003, 17 (14): 2063-2070. 10.1097/00002030-200309260-00007.CrossRefPubMed
6.
go back to reference Saenghirunvattana S: Effect of isoniazid prophylaxis on incidence of active tuberculosis among Thai HIV-infected individuals. J Med Assoc Thai. 1996, 79 (5): 265-267. Saenghirunvattana S: Effect of isoniazid prophylaxis on incidence of active tuberculosis among Thai HIV-infected individuals. J Med Assoc Thai. 1996, 79 (5): 265-267.
7.
go back to reference Mwinga A, Hosp M, Godfrey - Faussett P, Quigley M, Mwaba P, Mugala BN, Nyirends O, Luo N, Pobee J, Elliott AM, McAdam KP, Porter JD: Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS. 1998, 12 (18): 2447-2457. 10.1097/00002030-199818000-00014.CrossRefPubMed Mwinga A, Hosp M, Godfrey - Faussett P, Quigley M, Mwaba P, Mugala BN, Nyirends O, Luo N, Pobee J, Elliott AM, McAdam KP, Porter JD: Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS. 1998, 12 (18): 2447-2457. 10.1097/00002030-199818000-00014.CrossRefPubMed
8.
go back to reference WHO: Three I's Meeting: Intensified Case Finding (ICF), IPT (IPT) and TB Infection Control (IC) for PLHIV. Report of a WHO Joint HIV and TB Department Meeting. 2008, World Health Organization HIV Department, Geneva, Switzerland WHO: Three I's Meeting: Intensified Case Finding (ICF), IPT (IPT) and TB Infection Control (IC) for PLHIV. Report of a WHO Joint HIV and TB Department Meeting. 2008, World Health Organization HIV Department, Geneva, Switzerland
9.
go back to reference Szakacs TA, Wilson D, Cameron DW, Clark M, Kocheleff P, Muller FJ, McCArthy AE: Adherence with isoniazid for prevention of tuberculosis among HIV infected adults in South Africa. BMC Infectious Diseases. 2006, 6.97-doi 10.1186/147-2334-6.97 Szakacs TA, Wilson D, Cameron DW, Clark M, Kocheleff P, Muller FJ, McCArthy AE: Adherence with isoniazid for prevention of tuberculosis among HIV infected adults in South Africa. BMC Infectious Diseases. 2006, 6.97-doi 10.1186/147-2334-6.97
10.
go back to reference Rowe KA, Makhubele B, Hargreaves JH, Porter JD, Hausler HP, Pronyk PM: Adherence to preventive therapy for HIV-positive patients in rural South Africa: Implications for antiretroviral delivery in resource-poor settings. INT J TUBERC LUNG DIS. 2005, 9 (3): 263-269.PubMed Rowe KA, Makhubele B, Hargreaves JH, Porter JD, Hausler HP, Pronyk PM: Adherence to preventive therapy for HIV-positive patients in rural South Africa: Implications for antiretroviral delivery in resource-poor settings. INT J TUBERC LUNG DIS. 2005, 9 (3): 263-269.PubMed
12.
go back to reference Hoa NP, Thorson AE, Long NH, Diwan VK: Knowledge of TB and associated health-seeking behavior among rural Vietnamese. Scand J Public Health. 2003, 31: 59-65. 10.1080/14034950310015121.CrossRef Hoa NP, Thorson AE, Long NH, Diwan VK: Knowledge of TB and associated health-seeking behavior among rural Vietnamese. Scand J Public Health. 2003, 31: 59-65. 10.1080/14034950310015121.CrossRef
14.
go back to reference World Health Organization: Policy statement on preventive therapy against TB in PLHIV: Report of a meeting held in Geneva 18-20 February. 1998, World Health Organization Global TB Programme and UNAIDS World Health Organization: Policy statement on preventive therapy against TB in PLHIV: Report of a meeting held in Geneva 18-20 February. 1998, World Health Organization Global TB Programme and UNAIDS
15.
go back to reference World Health Organization: Global TB Control: Surveillance, Planning, Financing. 2008, Geneva, World Health Organization, WHO Report 2008 World Health Organization: Global TB Control: Surveillance, Planning, Financing. 2008, Geneva, World Health Organization, WHO Report 2008
16.
go back to reference Girardi E: Feasibility of screening and preventive therapy for TB among intravenous drug users: The SerT/TB Study. International Conference on AIDS. Int Conf AIDS.; 12: 136 (abstract no. 13251). 1998, Centro Riferimento AIDS IRCCS L. Spallanzani, Rome, Italy Girardi E: Feasibility of screening and preventive therapy for TB among intravenous drug users: The SerT/TB Study. International Conference on AIDS. Int Conf AIDS.; 12: 136 (abstract no. 13251). 1998, Centro Riferimento AIDS IRCCS L. Spallanzani, Rome, Italy
Metadata
Title
Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, Ethiopia
Authors
Amenu Wesen
Getnet Mitike
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC International Health and Human Rights / Issue 1/2012
Electronic ISSN: 1472-698X
DOI
https://doi.org/10.1186/1472-698X-12-2

Other articles of this Issue 1/2012

BMC International Health and Human Rights 1/2012 Go to the issue